Published September 23, 2026
| Version v1
Publication
Open
Translating Pre-clinical rVSV Success into Field-Ready Vaccines for Bundibugyo Ebolavirus: Lessons from ERVEBO® and Recombinant Albumin
Authors/Creators
Description
A Scientific Review of Post-Exposure Protection (Woolsey et al., J Infect Dis 2023), Clinical Lineage from the Guinea Ring and PREVAC Trials, Manufacturing and Formulation Considerations for the 2026 Democratic Republic of the Congo Bundibugyo Outbreak
Files
rVSV_Vectors_Exbumin_Optibumin_Bundibugyo_SDeeter_MStathos_23SEP26.pdf
Files
(377.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:afa23a235dbc431f1a2ebda03c5aa35d
|
377.3 kB | Preview Download |